Trial intelligence / Profile preview

Phase III randomized double-blind trial of icariin soft capsules versus Huachansu tablets as first-line treatment for biomarker-positive unresectable hepatocellular carcinoma

CTR20221588Phase 3Active

Sponsor

Shenogen Pharma Group

Start

Mar 2023

Modality

Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules

Countries

1